154 related articles for article (PubMed ID: 38779903)
21. Adverse effects of non-steroidal anti-inflammatory drugs in patients with viral respiratory infections: rapid systematic review.
von Philipsborn P; Biallas R; Burns J; Drees S; Geffert K; Movsisyan A; Pfadenhauer LM; Sell K; Strahwald B; Stratil JM; Rehfuess E
BMJ Open; 2020 Nov; 10(11):e040990. PubMed ID: 33444207
[TBL] [Abstract][Full Text] [Related]
22. NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects.
Kelleni MT
Expert Rev Anti Infect Ther; 2022 Jan; 20(1):17-21. PubMed ID: 34088250
[TBL] [Abstract][Full Text] [Related]
23. [Respiratory complaints in the time of COVID-19].
Loogman MCM; de Jong N; Platteel TN; Bouma M; Verheij TJM; Opstelten W
Ned Tijdschr Geneeskd; 2020 Mar; 164():. PubMed ID: 32392007
[TBL] [Abstract][Full Text] [Related]
24. Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents.
Perico N; Cortinovis M; Suter F; Remuzzi G
Lancet Infect Dis; 2023 Jan; 23(1):e22-e33. PubMed ID: 36030796
[TBL] [Abstract][Full Text] [Related]
25. Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID-19.
Sokolowska M; Rovati GE; Diamant Z; Untersmayr E; Schwarze J; Lukasik Z; Sava F; Angelina A; Palomares O; Akdis CA; O'Mahony L; Jesenak M; Pfaar O; Torres MJ; Sanak M; Dahlén SE; Woszczek G
Allergy; 2022 Aug; 77(8):2337-2354. PubMed ID: 35174512
[TBL] [Abstract][Full Text] [Related]
26. Serious Clinical Outcomes of COVID-19 Related to Acetaminophen or NSAIDs from a Nationwide Population-Based Cohort Study.
Kim JW; Yoon S; Lee J; Lee S
Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36900840
[TBL] [Abstract][Full Text] [Related]
27. Effect of anti-inflammatory drugs on the storm of inflammatory factors in respiratory tract infection caused by SARS-CoV-2: an updated meta-analysis.
Qin Z; Li Y; Sun W; Lu Y; Zhang N; Yang R; Liu Y; Tang L; Liu Q
Front Public Health; 2023; 11():1198987. PubMed ID: 37920591
[TBL] [Abstract][Full Text] [Related]
28. Nonsteroidal anti-inflammatory drugs and glucocorticoids in COVID-19.
Ricciotti E; Laudanski K; FitzGerald GA
Adv Biol Regul; 2021 Aug; 81():100818. PubMed ID: 34303107
[TBL] [Abstract][Full Text] [Related]
29. Non-steroidal anti-inflammatory agent use may not be associated with mortality of coronavirus disease 19.
Park J; Lee SH; You SC; Kim J; Yang K
Sci Rep; 2021 Mar; 11(1):5087. PubMed ID: 33658615
[TBL] [Abstract][Full Text] [Related]
30. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
[TBL] [Abstract][Full Text] [Related]
31. Early use of non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical outcomes.
Kelleni MT
Biomed Pharmacother; 2021 Jan; 133():110982. PubMed ID: 33197762
[TBL] [Abstract][Full Text] [Related]
32. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
[TBL] [Abstract][Full Text] [Related]
33. NSAIDs for analgesia in the era of COVID-19.
Herzberg DL; Sukumaran HP; Viscusi E
Reg Anesth Pain Med; 2020 Sep; 45(9):677-678. PubMed ID: 32499385
[TBL] [Abstract][Full Text] [Related]
34. Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial.
Brown LK; Freemantle N; Breuer J; Dehbi HM; Chowdhury K; Jones G; Ikeji F; Ndoutoumou A; Santhirakumar K; Longley N; Checkley AM; Standing JF; Lowe DM
Trials; 2021 Mar; 22(1):193. PubMed ID: 33685502
[TBL] [Abstract][Full Text] [Related]
35. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R
Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014
[TBL] [Abstract][Full Text] [Related]
36. Use of Nonsteroidal Anti-inflammatory Drugs for COVID-19 Infection: Adjunct Therapy?
Zhao D; Zhang S; Igawa T; Frishman W
Cardiol Rev; 2020; 28(6):303-307. PubMed ID: 33017365
[TBL] [Abstract][Full Text] [Related]
37. Rheumatologic Manifestations of Post SARS-CoV-2 Infection: A Case Series.
Metyas S; Chen C; Aung T; Ballester A; Cheav S
Curr Rheumatol Rev; 2022; 18(4):346-351. PubMed ID: 35152867
[TBL] [Abstract][Full Text] [Related]
38. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
39. Reactive arthritis after SARS-CoV-2 infection.
Dombret S; Skapenko A; Schulze-Koops H
RMD Open; 2022 Sep; 8(2):. PubMed ID: 36096524
[TBL] [Abstract][Full Text] [Related]
40. Pericarditis after SARS-CoV-2 Infection: Another Pebble in the Mosaic of Long COVID?
Carubbi F; Alunno A; Leone S; Di Gregorio N; Mancini B; Viscido A; Del Pinto R; Cicogna S; Grassi D; Ferri C
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
